JP2024016237A5 - - Google Patents

Download PDF

Info

Publication number
JP2024016237A5
JP2024016237A5 JP2023192683A JP2023192683A JP2024016237A5 JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5 JP 2023192683 A JP2023192683 A JP 2023192683A JP 2023192683 A JP2023192683 A JP 2023192683A JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5
Authority
JP
Japan
Prior art keywords
inhibitor
dose
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023192683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024016237A (ja
JP7811933B2 (ja
Filing date
Publication date
Priority claimed from JP2020505844A external-priority patent/JP7417515B2/ja
Priority claimed from PCT/US2018/045195 external-priority patent/WO2019028367A1/en
Application filed filed Critical
Publication of JP2024016237A publication Critical patent/JP2024016237A/ja
Publication of JP2024016237A5 publication Critical patent/JP2024016237A5/ja
Application granted granted Critical
Publication of JP7811933B2 publication Critical patent/JP7811933B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023192683A 2017-08-04 2023-11-13 活動性好酸球性食道炎を治療する方法 Active JP7811933B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762541242P 2017-08-04 2017-08-04
US62/541,242 2017-08-04
US201762561593P 2017-09-21 2017-09-21
US62/561,593 2017-09-21
EP18305252.1 2018-03-08
EP18305252 2018-03-08
JP2020505844A JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法
PCT/US2018/045195 WO2019028367A1 (en) 2017-08-04 2018-08-03 METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020505844A Division JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Publications (3)

Publication Number Publication Date
JP2024016237A JP2024016237A (ja) 2024-02-06
JP2024016237A5 true JP2024016237A5 (enExample) 2024-10-17
JP7811933B2 JP7811933B2 (ja) 2026-02-06

Family

ID=63113646

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020505844A Active JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法
JP2023192683A Active JP7811933B2 (ja) 2017-08-04 2023-11-13 活動性好酸球性食道炎を治療する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020505844A Active JP7417515B2 (ja) 2017-08-04 2018-08-03 活動性好酸球性食道炎を治療する方法

Country Status (9)

Country Link
EP (1) EP3661551A1 (enExample)
JP (2) JP7417515B2 (enExample)
KR (2) KR102719720B1 (enExample)
CN (1) CN111032084A (enExample)
AU (2) AU2018311981B2 (enExample)
CA (1) CA3071528A1 (enExample)
IL (2) IL315556A (enExample)
MA (1) MA49744A (enExample)
MX (2) MX2020001305A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7862322B2 (ja) * 2020-05-22 2026-05-19 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Il-4r阻害剤の投与により好酸球性食道炎を処置する方法
GB202102277D0 (en) * 2021-02-18 2021-04-07 Nordic Bioscience As Immunoassay for detecting Eosinophilic Esophagitis
EP4091615A1 (en) * 2021-05-20 2022-11-23 Dr. Falk Pharma Gmbh Orodispersible effervescent tablet comprising budesonide for use in the treatment of eosinophilic esophagitis
CN117085122A (zh) * 2022-04-29 2023-11-21 中山康方生物医药有限公司 抗人il-4ra的抗体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI634900B (zh) 2013-07-11 2018-09-11 再生元醫藥公司 藉由投與il-4r抑制劑治療嗜酸性食道炎的方法
JP6715767B2 (ja) * 2013-10-23 2020-07-01 ジェネンテック, インコーポレイテッド 好酸球性疾患の診断及び治療方法
CN107428828A (zh) * 2015-03-11 2017-12-01 葛兰素史密斯克莱知识产权发展有限公司 Tslp结合蛋白

Similar Documents

Publication Publication Date Title
JP2023520676A5 (enExample)
CN105392497B (zh) 以il-4r抑制剂治疗嗜酸性食管炎的方法
RU2015109716A (ru) Способы лечения или предотвращения астмы посредством введения антагониста il-4r
JP2022160685A5 (enExample)
Casale Biologics and biomarkers for asthma, urticaria, and nasal polyposis
JP2022169718A5 (enExample)
JP2023515271A5 (enExample)
JP2019531273A5 (enExample)
RU2016101632A (ru) Способы лечения полипоза носа путем введения антагониста il-4r
JP2022526738A5 (enExample)
JP2018158934A (ja) 抗il−5抗体を投与するための方法
JP2021530438A5 (enExample)
JP2020500152A5 (enExample)
JP2016528207A5 (enExample)
RU2019111921A (ru) Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r
JP2019529560A5 (enExample)
JP2024530954A5 (enExample)
JP2025102888A (ja) Il-17アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2021502349A5 (enExample)
KR20140061403A (ko) 항―il―13 항체를 이용하여 천식을 치료하기 위한 방법 및 조성물
JP2020502261A5 (enExample)
JP2020529434A5 (enExample)
JP2025072440A5 (enExample)
JP2022542472A5 (enExample)
JP2025501239A5 (enExample)